Genomic Endometrial Expression in Obesity

Determine if different genomic endometrial expression exists during embryo implantation in obese women in comparison with non obese women.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity and Embryo Implantation Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Instituto Valenciano de Infertilidad Spain

Valencia, 46015, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

group A: non obese oocyte donors (BMI: 18 - 29 kg. /m2)with proven fertility
group B: obese oocyte donors: (BMI: >29 kg./m2)with proven fertility
group C: obese (BMI: >29 kg./m2) infertile patients,

Exclusion criteria

recurrent miscarriage

Treatment and study plan

endometrial biopsy

Procedure

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Instituto Valenciano de Infertilidad, IVI VALENCIA

Other

Registry information

Important dates

Study start: 2007
Primary completion: 2009
Study completion: 2009
First posted: Jul 25, 2007
Registry last updated: Apr 2, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed